Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,045.00
+120.00 (3.06%)
At close: Jun 12, 2026

John Keells Holdings Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14,1953,1386,5257,9872,35113,799
Short-Term Investments
1,9802,0202,2115,33011,60014,880
Trading Asset Securities
--1,2524,40412,44835,376
Cash & Short-Term Investments
16,1755,1589,98817,72126,40064,055
Cash Growth
154.55%-48.36%-43.64%-32.88%-58.79%-29.36%
Accounts Receivable
-9,73911,900-8,84710,712
Other Receivables
-355.87368.04-347.192,428
Receivables
-10,22314,409-9,69413,163
Inventory
14,43415,84919,63712,99411,19916,034
Prepaid Expenses
-826.97269.57-20.8421.39
Other Current Assets
10,5671,482103.3314,423248.442,659
Total Current Assets
41,17633,53944,40745,13847,56296,333
Property, Plant & Equipment
25,52726,27231,81425,52133,96832,807
Long-Term Investments
85,13686,28494,56091,48495,24245,857
Other Intangible Assets
3,5603,6864,1904,6315,5748,612
Long-Term Accounts Receivable
-0-0---
Long-Term Deferred Tax Assets
-----3,431
Long-Term Deferred Charges
14,47214,7167,8646,2093,4372,880
Other Long-Term Assets
879.45984.371,614662.931,006653.97
Total Assets
170,750165,481184,449173,647187,074194,471
Accounts Payable
-7,76511,82710,6326,1526,622
Accrued Expenses
-1,5641,5751,5321,8482,167
Short-Term Debt
35,07740,92934,47639,99652,57267,993
Current Portion of Long-Term Debt
----5,604867.11
Current Portion of Leases
716.17878.71,182624.62653.17610.93
Current Income Taxes Payable
--30.1---
Current Unearned Revenue
-1,8511,9063,5043,6853,685
Other Current Liabilities
22,05324,72421,2158,4908,7467,078
Total Current Liabilities
57,84677,71272,21164,77979,26189,023
Long-Term Debt
-----13,958
Long-Term Leases
366.06533.97841.95994.181,481685.36
Pension & Post-Retirement Benefits
3,5494,0603,8072,6001,8092,288
Long-Term Deferred Tax Liabilities
972.12972.12923.51923.51927.931,823
Other Long-Term Liabilities
10,2809,538238.67283.74130.07150.4
Total Liabilities
73,01392,81678,02269,58083,609107,928
Common Stock
151,799125,262125,262120,529117,02284,953
Additional Paid-In Capital
255,671250,604249,419245,296243,684216,611
Retained Earnings
-309,351-303,792-271,829-261,313-257,365-216,914
Treasury Stock
-10.05-10.05-13.12-18.19--
Comprehensive Income & Other
-372.6601.243,588-427.4125.39469.82
Total Common Equity
97,73772,665106,427104,067103,46685,120
Minority Interest
-----1,422
Shareholders' Equity
97,73772,665106,427104,067103,46686,542
Total Liabilities & Equity
170,750165,481184,449173,647187,074194,471
Total Debt
36,16042,34136,50041,61560,31084,115
Net Cash (Debt)
-19,985-37,183-26,512-23,894-33,910-20,060
Net Cash Per Share
-398.01-751.00-555.09-500.74-779.45-615.13
Filing Date Shares Outstanding
52.4449.5549.3847.2146.8133.98
Total Common Shares Outstanding
52.4449.5549.3847.2146.8133.98
Working Capital
-16,670-44,173-27,804-19,640-31,6997,310
Book Value Per Share
1863.821466.512155.282204.512210.402504.91
Tangible Book Value
94,17768,979102,23799,43697,89276,508
Tangible Book Value Per Share
1795.931392.122070.442106.412091.332251.47
Land
6,0376,0376,0376,0376,0376,183
Buildings
6,70110,6946,8356,6786,5577,886
Machinery
11,68623,76623,15323,40120,01522,216
Construction In Progress
37.547.237,5981,94312,1329,142